Predicting Outcome Following Standardized Exercise Therapy in Knee Osteoarthritis Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04123756 |
Recruitment Status :
Terminated
(Recruitment issues due to the corona virus and lack of funding to continue)
First Posted : October 11, 2019
Last Update Posted : January 14, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Pain sensitization has been associated with pain severity in people with knee osteoarthritis (KOA) and a neuropathic pain component has been identified in up to 30% of KOA patients. Mechanistic pain profiling aims to identify the underlying mechanisms in the peripheral and central nervous systems, which are associated to the clinical pain.
In addition, the mechanisms underlying the pain relieving effect of standardized exercise therapy are largely unknown, but it is hypothesized that they are linked to the patient's ability to activate the descending pain inhibitory pathways (conditioned pain modulation, CPM) in the central nervous system. Mechanistic pain profiling including CPM have been used prognostic to identify responders to treatment, but these measures as a prognostic tool for standardized exercise therapy has not been investigated.
The primary aim of this study is to investigate if mechanistic pain profiling alone or in combination with clinical pain measures before standardized exercise therapy can predict the patients' pain reduction following the exercise therapy program
Condition or disease | Intervention/treatment |
---|---|
Knee Osteoarthritis | Behavioral: standardized exercise therapy for knee OA patients |
Study Type : | Observational |
Actual Enrollment : | 12 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Smerteprofiler Som Redskab Til at prædiktere Effekten af 6-8 Ugers GLA:D®-forløb Hos Patienter Med Smertefuld Slidgigt i knæene |
Actual Study Start Date : | October 1, 2019 |
Actual Primary Completion Date : | December 31, 2020 |
Actual Study Completion Date : | December 31, 2020 |

- Behavioral: standardized exercise therapy for knee OA patients
Standardized exercise therapy for 6-8 weeks (two times per week).
- pain reduction [ Time Frame: 1-2 weeks after last exercise session ]Pain measured on a numerical rating scale from 0 (no pain) to 10 (worst pain imaginable)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- The American College of Rheumatology for clinical knee osteoarthritis (excluding radiological OA assessment)
Exclusion Criteria:
- Known factors to influence pain and pain sensitization

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04123756
Denmark | |
FysioDanmark Aarhus | |
Aarhus, Denmark, 8000 |
Responsible Party: | Kristian Kjær Petersen, Associate Professor, M.Sc., Ph.D., Aalborg University |
ClinicalTrials.gov Identifier: | NCT04123756 |
Other Study ID Numbers: |
N-20190045 |
First Posted: | October 11, 2019 Key Record Dates |
Last Update Posted: | January 14, 2021 |
Last Verified: | January 2021 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Osteoarthritis Osteoarthritis, Knee Arthritis |
Joint Diseases Musculoskeletal Diseases Rheumatic Diseases |